Author

P.A. Murray

Observed names: P Murray, P. Murray, PA Murray

Institutions: University of Leeds, NHS Lothian, Institute of Cancer Research, Velindre NHS Trust, Cancer Research UK, University of Edinburgh

Observed institutions: St Bartholomew's Hospital, University of Leeds, St George's Hospital, NHS Lothian, Institute of Cancer Research, St George's, University of London, Velindre NHS Trust, Cancer Research UK, Charing Cross Hospital, Essex County Hospital, University of Edinburgh

OpenAlex ID: A5108495904

Ifosfamide Encephalopathy

2006 · T. Ajithkumar, C. Parkinson, et al. · Clinical Oncology · 113

The prognostic significance of transforming growth factors in human breast cancer

1993 · PA Murray, P Barrett-Lee, et al. · British Journal of Cancer · 85

A novel continuous infusional 5-fluorouracil-based chemotherapy regimen compared with conventional chemotherapy in theneo-adjuvant treatment of early breast cancer: 5 year results of the TOPIC trial

2004 · I.E. Smith, R.P. A’Hern, et al. · Annals of Oncology · 60

4-hydroxyandrostenedione – further clinical and extended endocrine observations

1990 · T Pickles, L Perry, et al. · British Journal of Cancer · 41

Information given to patients about adverse effects of radiotherapy: a survey of patients' views

2004 · G.C. Barnett, S.C. Charman, et al. · Clinical Oncology · 26

Radiotherapy for stage I Hodgkin's disease: 20 years experience at St Bartholomew's Hospital

1990 · TS Ganesan, PFM Wrigley, et al. · British Journal of Cancer · 24

The effect of endocrine therapy on the levels of oestrogen and progesterone receptor and transforming growth factor-β1 in metastatic human breast cancer: an immunocytochemical study

1994 · P.A. Murray, J. Gomm, et al. · European Journal of Cancer · 15

Cerebellar Toxicity with Capecitabine in a Patient with Metastatic Breast Cancer

2008 · M. Mukesh, P. Murray · Clinical Oncology · 9

Carboplatin AUC8 in combination with etoposide and bleomycin in the treatment of intermediate and poor-risk metastatic germ cell tumours: a phase II study

2001 · J. Shamash, B. McLaren, et al. · Cancer Chemotherapy and Pharmacology · 4

A UK survey of tamoxifen prescribing and oestrogen receptor status

2002 · K.S. Madhavan, P.A. Murray · The Breast · 3

Abstract P5-10-07: TACT2 Randomised Adjuvant Trial in Early Breast Cancer (EBC): Tolerability and Toxicity of Standard 3 Weekly Epirubicin (E) Versus Accelerated Epirubicin (aE) Followed by Capecitabine (X) or CMF in 129 UK Hospitals (CRUK/05/019)

2010 · JM Bliss, P Canney, et al. · Cancer Research · 1

The prognostic significance of transcripts for transforming growth factor alpha and beta1 and epidermal growth factor receptor in primary breast cancer

1990 · RC Coombee, P Murray, et al. · European Journal of Cancer and Clinical Oncology · 1

Works count: 12

Citation count: 382

H-index: 8

I10-index: 7